Va Distal Lateral Humerus Bone Plate

Name: Va Distal Lateral Humerus Bone Plate
Brand: Shanghai A-Orth Medical Co., Ltd.
SKU: 2224279475

Shanghai, ChinaShanghai A-Orth Medical Co., Ltd.

US$75.00-85.00

1 Piece

Sample price:US$85.00/piece.Request sample

Product profile

Customization

Available

Certification

FDA, QS, ISO, CE

Disinfection

Model NO.

YSZ47

Application

Distal Humeral Fracture

Material

Titanium

Product Name

LCP Va Distal Lateral Posterior Humeral Plate 2.7/

Holes

10-20

Length

120-198mm

Left/Right

Thickness

2.7mm

Matched Instruments

Small Fragment Locking Plate System Instruments

Transport Package

with Inner Transparent PP Bag, Ship in Carton.

Origin

China

HS Code

9021100000

Production Capacity

10, 000 Pieces/Year

Key features

Titanium Material: Made from high-grade titanium for biocompatibility and durability.

FDA and CE Certified: Holds FDA, QS, ISO, and CE certifications for global compliance.

Variable Angle Locking: MALP system allows flexible fixation angles to the proximal joint facet.

Customizable Plate Length: Available in lengths ranging from 120mm to 198mm.

Customizable Hole Count: Offers 10 to 20 holes to fit various fracture patterns.

Left/Right Side Options: Designed specifically for both left and right humerus sides.

Biological Fixation: Protects blood supply with no need for cortex bone compression.

Integrated Pin Design: Prevents spare parts from falling off during surgery.

Company profile

Shanghai A-Orth Medical Co., Ltd.

Shanghai, China

Business Type: Trading CompanyExport Year: 2016-02-01 CertifiedNearest Port: Shanghai PortAverage Response Time: ≤10.22h CertifiedTerms of Payment: T/T, Western Union, Small-amount payment CertifiedInternational Commercial Terms(Incoterms): FOB, CIF

AI-Powered supplier vetting

SummaryShanghai A-Orth Medical Co., Ltd. is a China-based trading company focused on orthopedic implants, spine systems, instruments, and power tools. It reports self-operated import and export rights, began exporting in 2016, and derives 90% of total sales from exports. The supplier lists ISO 9000, ISO 13485, ISO 9001, GMP, and QC 080000 certifications. Reported operational capabilities include more than 10 production lines, 21–30 R&D engineers, 21–30 quality-control staff, specified annual product volumes, broad export-market coverage, and an off-peak lead time within 15 working days. However, the available information does not establish after-sales procedures, customization services, financial reliability, or verified customer case details. The trade record shows one transaction and one associated buyer, which is insufficient for a broad customer-track-record assessment.

Supplier typeThe supplier is explicitly identified as a trading company, with its business focused on health and medicine and its product range covering trauma implants, spine implants, instruments, and power tools. Its description indicates involvement in the sale of orthopedic and other medical products, while the production-related data suggests access to manufacturing capabilities.

CertificationsThe supplier lists ISO 9000, ISO 13485, ISO 9001, GMP, and QC 080000 certifications. ISO 13485 and GMP are directly relevant to medical-device quality and manufacturing controls, although the provided information does not include certificate validity periods or scope details.

R&D capabilityThe supplier reports 21–30 R&D engineers and describes strong technical capability, with products developed in conjunction with clinical experience. Its orthopedic portfolio includes specialized products such as interbody fusion cages, pedicle screws, locking systems, and power tools, providing evidence of product-development activity but not proof of proprietary innovation or patents.

Production capacityThe supplier reports more than 10 production lines, 21–30 quality-control staff, and defined annual outputs including 300,000 titanium screws, 50,000 locking plates, 50,000 interlocking nails, 10,000 interbody fusion cages, and 5,000 instrument sets. It also reports an off-peak lead time within 15 working days, supporting a positive assessment of stated production capacity and fulfillment readiness.